0.6862USD-0.38%Mkt Cap: 22.88M USDP/E: —Last update: 2026-06-01
VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies to treat chronic inflammatory and immune-mediated conditions. The company's lead program is repibresib gel (VYN201), a t…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap22.88M USD
Enterprise Value-2.18M USD
Revenue (TTM)454.00K USD
Gross Profit454.00K USD
Net Income (TTM)-26.48M USD
Revenue/Share0.0110 USD
Last Price0.6862 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees10
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.41
PEG—
EV/EBITDA0.09
EV/Revenue-4.81
P/S50.10
P/B0.92
EPS (TTM)-0.51
EPS (Forward)-1.65
52W Range
0.281024% of range1.960
52W High1.960 USD
52W Low0.2810 USD
Profitability
Gross Margin100.00%
Oper. Margin-4437.21%
EBITDA Margin0.00%
Profit Margin-4646.14%
ROE-95.38%
ROA-87.81%
Growth
Revenue Growth-57.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-33.12M USD
CapEx (TTM)—
FCF Margin-4429.74%
FCF Yield-87.88%
Net Debt-24.93M USD
Net Debt/EBITDA1.02
Balance Sheet
Debt/Equity0.00
Current Ratio20.86
Quick Ratio20.17
Book Value/Sh0.7390 USD
Cash/Share0.7470 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:18
Split DateFeb 13, 2023
Analyst Consensus
Rating—
Target (Mean)2.000 USD
Target Range2.000 USD – 2.000 USD
# Analysts1
Ownership
Shares Out.33.35M
Float32.55M
Insiders4.34%
Institutions41.71%
Short Interest
Short Ratio0.6d
Short % Float0.37%
Short % Out.0.37%
Shares Short122.31K
Short (prev mo.)100.38K
Technical
SMA 500.6398 (+7.2%)
SMA 2000.4935 (+39.1%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)198.59K
Avg Vol (10d)167.34K
Technical Indicators
RSI (14)62.9
MACD0.0118
MACD Signal0.0126
MACD Hist.-0.0008
BB Upper0.6915 USD
BB Middle0.6698 USD
BB Lower0.6482 USD
BB Width6.45%
ATR (14)0.0208 USD
Vol Ratio (20d)0.23x